First Manhattan’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-142
| Closed | -$383 | – | 1719 |
|
|
2022
Q4 | $383 | Hold |
142
| – | – | ﹤0.01% | 1619 |
|
|
2022
Q3 | $0 | Hold |
142
| – | – | ﹤0.01% | 1670 |
|
|
2022
Q2 | $0 | Hold |
142
| – | – | ﹤0.01% | 1685 |
|
|
2022
Q1 | $1K | Hold |
142
| – | – | ﹤0.01% | 1564 |
|
|
2021
Q4 | $2K | Hold |
142
| – | – | ﹤0.01% | 1494 |
|
|
2021
Q3 | $3K | Sell |
142
-154
| -52% | -$3.25K | ﹤0.01% | 1498 |
|
|
2021
Q2 | $18K | Hold |
296
| – | – | ﹤0.01% | 1178 |
|
|
2021
Q1 | $36K | Hold |
296
| – | – | ﹤0.01% | 1028 |
|
|
2020
Q4 | $33K | Sell |
296
-42
| -12% | -$4.68K | ﹤0.01% | 975 |
|
|
2020
Q3 | $40K | Sell |
338
-304
| -47% | -$36K | ﹤0.01% | 916 |
|
|
2020
Q2 | $79K | Buy |
+642
| New | +$79K | ﹤0.01% | 811 |
|
|
2020
Q1 | – | Sell |
-30,111
| Closed | -$10.1M | – | 1467 |
|
|
2019
Q4 | $10.1M | Sell |
30,111
-73
| -0.2% | -$24.4K | 0.05% | 166 |
|
|
2019
Q3 | $9.74M | Sell |
30,184
-735
| -2% | -$237K | 0.05% | 166 |
|
|
2019
Q2 | $13.3M | Sell |
30,919
-427
| -1% | -$184K | 0.07% | 137 |
|
|
2019
Q1 | $17.7M | Buy |
31,346
+12,938
| +70% | +$7.31M | 0.1% | 112 |
|
|
2018
Q4 | $5.46M | Buy |
18,408
+5,258
| +40% | +$1.56M | 0.03% | 228 |
|
|
2018
Q3 | $9.33M | Buy |
13,150
+12,726
| +3,001% | +$9.03M | 0.05% | 196 |
|
|
2018
Q2 | $248K | Buy |
+424
| New | +$248K | ﹤0.01% | 660 |
|